Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Sponsor: InduPro, Inc.
Summary
This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutaneous).
Official title: A Phase 1/2 Open-label Study of IDP-001 in Advanced or Metastatic Squamous Cell Lung Cancer and Other Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
132
Start Date
2026-06
Completion Date
2028-12
Last Updated
2026-07-27
Healthy Volunteers
No
Conditions
Interventions
IDP-001
IV infusion
Locations (4)
START Los Angeles
Los Angeles, California, United States
Hackensack Meridian - John Theurer Cancer Center
Edison, New Jersey, United States
START New York Long Island
Lake Success, New York, United States
START Dallas Forth Worth
Fort Worth, Texas, United States